RBF Capital, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
RBF Capital, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$2,216,000
+26.9%
611,850
+2.0%
0.12%
-35.1%
Q2 2020$1,746,000
+3.2%
600,0000.0%0.19%
-14.9%
Q1 2020$1,692,000
-13.1%
600,0000.0%0.22%
+18.8%
Q4 2019$1,947,000
+58.3%
600,000
+5.4%
0.19%
+34.8%
Q3 2019$1,230,000
-31.2%
569,3230.0%0.14%
-23.3%
Q2 2019$1,788,000
-15.6%
569,3230.0%0.18%
-27.7%
Q1 2019$2,118,000
+23.3%
569,323
-3.9%
0.25%
+11.2%
Q4 2018$1,718,000
+277.6%
592,413
+242.3%
0.22%
+357.1%
Q3 2018$455,000
+11.8%
173,0900.0%0.05%
+2.1%
Q2 2018$407,000
-19.9%
173,0900.0%0.05%
-21.3%
Q1 2018$508,000
+7.2%
173,0900.0%0.06%
+17.3%
Q4 2017$474,000
-21.3%
173,090
-2.5%
0.05%
-31.6%
Q3 2017$602,000
+37.4%
177,4450.0%0.08%
+33.3%
Q2 2017$438,000
+8.7%
177,4450.0%0.06%
+3.6%
Q1 2017$403,000
-25.4%
177,445
-29.4%
0.06%
-28.6%
Q4 2016$540,000
-41.2%
251,421
-8.2%
0.08%
-51.0%
Q3 2016$918,000
+6.7%
273,9760.0%0.16%
-8.2%
Q2 2016$860,000
-5.7%
273,9760.0%0.17%
-2.3%
Q1 2016$912,000
-6.0%
273,9760.0%0.18%
-3.8%
Q4 2015$970,000273,9760.18%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders